Page 73 - Read Online

Novati et al. Ageing Neur Dis 2022;2:17 https://dx.doi.org/10.20517/and.2022.19 Page 27 of 29

236. Clemensson EKH, Clemensson LE, Fabry B, Riess O, Nguyen HP, Fleming SM. Further investigation of phenotypes and
confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease. PLoS
ONE 2017;12:e0173232. DOI PubMed PMC
237. Jansson EK, Clemens LE, Riess O, Nguyen HP. Reduced motivation in the BACHD rat model of Huntington disease is dependent on
the choice of food deprivation strategy. PLoS One 2014;9:e105662. DOI PubMed PMC
238. Beste C, Saft C, Andrich J, Gold R, Falkenstein M. Response inhibition in Huntington’s disease-a study using ERPs and sLORETA.
Neuropsychologia 2008;46:1290-7. DOI PubMed
239. Rao JA, Harrington DL, Durgerian S, et al. Disruption of response inhibition circuits in prodromal Huntington disease. Cortex
2014;58:72-85. DOI PubMed PMC
240. Curtin PC, Farrar AM, Oakeshott S, et al. Cognitive training at a young age attenuates deficits in the zQ175 mouse model of HD.
Front Behav Neurosci 2015;9:361. DOI PubMed PMC
241. Oakeshott S, Farrar A, Port R, et al. Deficits in a simple visual go/no-go discrimination task in two mouse models of Huntington’s
disease. PLoS Curr 2013;5:ecurrents. DOI PubMed PMC
242. Clemensson EKH, Novati A, Clemensson LE, Riess O, Nguyen HP. The BACHD rat model of Huntington disease shows slowed
learning in a Go/No-Go-like test of visual discrimination. Behav Brain Res 2019;359:116-26. DOI PubMed
243. El Massioui N, Lamirault C, Yagüe S, et al. Impaired decision making and loss of inhibitory-control in a rat model of Huntington
disease. Front Behav Neurosci 2016;10:204. DOI PubMed PMC
244. Manfré G, Doyère V, Bossi S, Riess O, Nguyen HP, El Massioui N. Impulsivity trait in the early symptomatic BACHD transgenic rat
model of Huntington disease. Behav Brain Res 2016;299:6-10. DOI PubMed
245. Plank AC, Canneva F, Raber KA, et al. Early alterations in operant performance and prominent huntingtin aggregation in a congenic
F344 rat line of the classical CAG n51trunc model of Huntington disease. Front Neurosci 2018;12:11. DOI PubMed PMC
246. Winstanley CA. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J
Pharmacol 2011;164:1301-21. DOI PubMed PMC
247. Beste C, Saft C, Andrich J, Müller T, Gold R, Falkenstein M. Time processing in Huntington’s disease: a group-control study. PLoS
One 2007;2:e1263. DOI PubMed PMC
248. Lawrence AD, Watkins LH, Sahakian BJ, Hodges JR, Robbins TW. Visual object and visuospatial cognition in Huntington’s disease:
implications for information processing in corticostriatal circuits. Brain 2000;123 ( Pt 7):1349-64. DOI PubMed
249. Brooks S, Fielding S, Döbrössy M, von Hörsten S, Dunnett S. Subtle but progressive cognitive deficits in the female tgHD
hemizygote rat as demonstrated by operant SILT performance. Brain Res Bull 2009;79:310-5. DOI PubMed
250. Fink KD, Rossignol J, Crane AT, et al. Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington’s disease.
Behav Neurosci 2012;126:479-87. DOI PubMed
251. Zeef DH, van Goethem NP, Vlamings R, et al. Memory deficits in the transgenic rat model of Huntington’s disease. Behav Brain Res
2012;227:194-8. DOI PubMed
252. Abada YS, Nguyen HP, Ellenbroek B, Schreiber R. Reversal learning and associative memory impairments in a BACHD rat model
for Huntington disease. PLoS One 2013;8:e71633. DOI PubMed PMC
253. Clemensson EK, Clemensson LE, Riess O, Nguyen HP. The BACHD rat model of Huntington disease shows signs of fronto-striatal
dysfunction in two operant conditioning tests of short-term memory. PLoS One 2017;12:e0169051. DOI PubMed PMC
254. Adjeroud N, Yagüe S, Yu-Taeger L, et al. Reduced impact of emotion on choice behavior in presymptomatic BACHD rats, a
transgenic rodent model for Huntington Disease. Neurobiol Learn Mem 2015;125:249-57. DOI PubMed
255. Brown A, Sewell K, Fisher CA. Characterisation of aggression in Huntington’s disease: rates, types and antecedents in an inpatient
rehabilitation setting. J Clin Nurs 2017;26:2922-31. DOI PubMed
256. Kempnich CL, Andrews SC, Fisher F, Wong D, Georgiou-Karistianis N, Stout JC. Emotion recognition correlates with social-
neuropsychiatric dysfunction in Huntington’s disease. J Int Neuropsychol Soc 2018;24:417-23. DOI PubMed
257. Mason SL, Schaepers M, Barker RA. Problems with social cognition and decision-making in Huntington’s disease: why is it
important? Brain Sci 2021;11:838. DOI PubMed PMC
258. Cheong RY, Tonetto S, von Hörsten S, Petersén Å. Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric
phenotype in the BACHD mouse model of Huntington disease. Psychoneuroendocrinology 2020;119:104773. DOI PubMed
259. Ciamei A, Morton AJ. Rigidity in social and emotional memory in the R6/2 mouse model of Huntington’s disease. Neurobiol Learn
Mem 2008;89:533-44. DOI PubMed
260. Pietropaolo S, Delage P, Cayzac S, Crusio WE, Cho YH. Sex-dependent changes in social behaviors in motor pre-symptomatic R6/1
mice. PLoS One 2011;6:e19965. DOI PubMed PMC
261. Rudenko O, Tkach V, Berezin V, Bock E. Effects of FGF receptor peptide agonists on animal behavior under normal and
pathological conditions. Neurosci Res 2010;68:35-43. DOI PubMed
262. Wood NI, Morton AJ. Social behaviour is impaired in the R6/2 mouse model of Huntington’s disease. J Huntingtons Dis 2015;4:61-
73. PubMed
263. Manfré G, Novati A, Faccini I, et al. BACHD rats expressing full-length mutant huntingtin exhibit differences in social behavior
compared to wild-type littermates. PLoS One 2018;13:e0192289. DOI PubMed PMC
264. Ko J. Neuroanatomical substrates of rodent social behavior: the medial prefrontal cortex and its projection patterns. Front Neural
Circuits 2017;11:41. DOI PubMed PMC